Mirum Pharmaceuticals stock surges 12% on trial results
Investing.com Gold reports: Mirum Pharmaceuticals stock surges 12% on trial results. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Mirum Pharmaceuticals stock surges 12% on trial results. Full body text was unavailable at ingest time, so this brief is based on headline context.